|
|
 |
|
|
Nov 14, 2005
Coremed, Inc. introduces IVE™, a
proprietary drug-delivery platform technology that improves protein
absorption within the gastrointestinal tract |
|
|
|
Aug 24, 2005
Coremed, Inc. signs joint venture with
China's major pharmas to develop Alveair™ inhalable insulin |
|
|
|
Jun 2, 2004 PRNewswire
Coremed, Inc. to Raise Funds and
Structure Strategic Alliances for Developing Inhalable and Oral
Insulin-Delivery Systems; Retains Resource Financial Corporation as
Financial Advisor |
|
|
|
Feb 6, 2004 PRNewswire
Based on Pre-Clinical Data, Coremed,
Inc.'s Alveair Insulin™ Achieves Better Insulin Bioavailability
Than Intravenous Injection of Analog Insulin |
|
|
|
Jan 20, 2004 PRNewswire
Coremed, Inc., Announces Positive
Data from First Human Trial of Alveair™ Insulin Pulmonary
Technology |
|
|
|
Dec 29, 2003
PRNewswire
Coremed, Inc., to Announce Human
Trials of Alveair™ Insulin Pulmonary Technology that Performs
Like a 'Needle-Less Syringe' |
|
|
|
Nov 6, 2003
PRNewswire
Coremed, Inc.,
Announces Major Breakthrough in Development of Alvair™,
Pulmonary-delivered Insulin, Based on Animal Study |
|
|
|
Aug 25, 2003 PRNewswire
Coremed, Inc.,
Announces Breakthrough in its Development of Intesulin™, Oral
Insulin, Based on Animal Food-Intake Data |
|
|
|
Jun 16, 2003 PRNewswire
Intesulin™,
Coremed Oral Insulin, Shows Efficacy When Delivered Directly into
Stomach |
|
|
|
Jun 10, 2003
PRNewswire
Coremed, inc.
Announces positive results from animal study of its Intesulin™ Oral
Insulin |
|
|
